Lantheus Holdings (FRA:0L8) Cyclically Adjusted PB Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0L8 Lantheus Holdings Inc FRA:0L8
80 GF Score
Price €87.60
GF Value €78.24
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Lantheus Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lantheus Holdings  (FRA:0L8) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Lantheus Holdings Cyclically Adjusted PB Ratio Related Terms


Lantheus Holdings Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Lantheus Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantheus Holdings Cyclically Adjusted PB Ratio Chart

Lantheus Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 32.03 21.12 8.95

Lantheus Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.98 8.12 9.82 9.79 13.38

FRA:0L8 vs HIMS, AMRX, KNSA: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lantheus Holdings Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Cyclically Adjusted PB Ratio falls into.


FRA:0L8
80GF Score
Lantheus Holdings Inc FRA:0L8
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lantheus Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Lantheus Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Lantheus Holdings's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=17.58/333.9520*333.9520
=17.580

Current CPI (Jun. 2026) = 333.9520.

Lantheus Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201609 -2.936 241.428 -4.061
201612 -2.747 241.432 -3.800
201703 -2.551 243.801 -3.494
201706 -2.047 244.955 -2.791
201709 -1.758 246.819 -2.379
201712 0.514 246.524 0.696
201803 0.720 249.554 0.964
201806 0.996 251.989 1.320
201809 1.242 252.439 1.643
201812 1.615 251.233 2.147
201903 1.909 254.202 2.508
201906 2.075 256.143 2.705
201909 2.365 256.759 3.076
201912 2.601 256.974 3.380
202003 2.715 258.115 3.513
202006 6.871 257.797 8.901
202009 6.551 260.280 8.405
202012 6.284 260.474 8.057
202103 6.664 264.877 8.402
202106 6.339 271.696 7.792
202109 6.368 274.310 7.753
202112 6.029 278.802 7.222
202203 6.761 287.504 7.853
202206 7.896 296.311 8.899
202209 9.465 296.808 10.649
202212 6.085 296.797 6.847
202303 5.889 301.836 6.516
202306 7.262 305.109 7.949
202309 9.454 307.789 10.258
202312 10.572 306.746 11.510
202403 12.395 312.332 13.253
202406 13.540 314.175 14.392
202409 14.919 315.301 15.802
202412 14.819 315.605 15.680
202503 15.585 319.799 16.275
202506 14.620 322.561 15.136
202509 14.367 324.800 14.772
202512 12.919 324.054 13.314
202603 18.193 330.213 18.399
202606 17.580 333.952 17.580

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Lantheus Holdings (FRA:0L8) Overvalued in 2026?

Based on GuruFocus' analysis, Lantheus Holdings stock appears to be overvalued. The current stock price of €87.60 is trading 12% above its estimated GF Value™ of €78.24. GuruFocus considers Lantheus Holdings to be Modestly Overvalued.

Key valuation signals for FRA:0L8:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €78.24 vs. price of €87.60 (12% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the FRA:0L8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lantheus Holdings Business Description

Address 201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
80GF Score

Get the complete analysis for FRA:0L8

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.60
Price
€78.24
GF Value